Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. - Wikidata - wikimedia - TriplyDB

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

http://www.wikidata.org/entity/Q33911613

about

Characterization of X chromosome inactivation using integrated analysis of whole-exome and mRNA sequencing Blood transcriptomics: applications in toxicology Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC Interactome mapping suggests new mechanistic details underlying Alzheimer's disease Multiple Aspects of Gene Dysregulation in Huntington's Disease Clinical and experimental applications of sodium phenylbutyrate Molecular diagnostics of neurodegenerative disorders Modeling Huntington's disease with induced pluripotent stem cells Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics Whole Blood Gene Expression Profiling in Preclinical and Clinical Cattle Infected with Atypical Bovine Spongiform Encephalopathy The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction.Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients Besides Huntington's disease, does brain-type creatine kinase play a role in other forms of hearing impairment resulting from a common pathological cause?Epigenetic and immune function profiles associated with posttraumatic stress disorder.Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.Mutant huntingtin impairs immune cell migration in Huntington disease.Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington's disease monkeys.The microarray data analysis process: from raw data to biological significance Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways.A practical platform for blood biomarker study by using global gene expression profiling of peripheral whole blood.SlimPLS: a method for feature selection in gene expression-based disease classification.Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency Age-associated chromatin relaxation is enhanced in Huntington's disease mice.Assessing the human immune system through blood transcriptomics.Pharmacology of epigenetics in brain disorders Genetic variation at the FTO locus influences RBL2 gene expression.Is human blood a good surrogate for brain tissue in transcriptional studies?Transcriptional analysis implicates endoplasmic reticulum stress in bovine spongiform encephalopathy Overlap of expression quantitative trait loci (eQTL) in human brain and blood.Blood-based biomarkers of Alzheimer's disease: challenging but feasible Meta-analysis for pathway enrichment analysis when combining multiple genomic studies.Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts.

P2860

Q21131890-65BDAC4C-6E1E-4A5E-AB47-7CC27DBC8D0E Q23919602-3754935F-3942-4D1C-818F-929FCE1BED69 Q24305544-846A2CB7-010B-4309-A724-C7E22C48576F Q24317038-9B3C93CA-916B-453F-B6DE-697A438C8EFC Q24605880-F6AA7934-1A92-40D0-9375-CA4021A4CFA5 Q24613511-D2E53EDC-B487-48EF-B014-98B3A99201E7 Q26786821-8D0B80C8-613B-4F02-B8AE-6DEF17ECCFEB Q27004209-01F750C6-0B9F-4DCB-8684-2BB66BA2FC68 Q27027555-35049B69-4D1B-4340-B94F-FEAB5437DC07 Q27314189-CE131CD1-839D-4E11-90E2-D9C8479201A2 Q27314681-DE71DF78-D84C-406A-AC89-0BCFDF3E8276 Q28396741-34506A78-3CC6-4497-8956-9017EFD375B5 Q28570135-18A2C623-17C9-4705-8F74-46AEF8F399D9 Q28743603-16052FDC-2F28-48A0-ACD9-FE2019777FCC Q28744223-33551458-96B9-42C8-B0F7-3604C16B0E09 Q29248581-418DB6DA-56F6-493B-A10B-23B06FD58AD0 Q30301131-249CB4FF-F45E-423E-B8C0-C71CCC1AC9D9 Q30455078-5A5A6B42-8C7C-4081-B701-AF1942252FF2 Q30474238-10FD5973-F94C-48C6-8011-704959E59095 Q30478641-9B0F8D55-63AA-4F1D-831B-75B6327B2796 Q30480013-88DC9E5E-CFF9-424B-A9A7-BF0ACFAB621C Q30530945-8CB57AC3-05A8-419D-9762-DF64CEB111F6 Q30543574-AACBFA71-15C0-4A5C-9B15-2F8711423C3C Q31047730-20B4EAC6-4811-41FA-9C75-D97089EF0B25 Q31067183-A9C026FB-5B62-4724-8434-06FEA58EAD1F Q33432836-BCC18356-8ED5-4A72-AFFA-360E859D964A Q33489546-DB956D83-4823-4A95-B6C4-EADAA729D020 Q33497640-27A185CB-69F4-432A-9DAD-0CAC1814A7DB Q33505860-7CC5F09E-2C30-4607-B5F4-FE0E993B1D32 Q33544002-4E2CB869-E846-4007-B63F-3681E4FAEDE3 Q33563614-20E5CCB3-0691-4FF9-B176-0A74B3696F02 Q33629522-ADEA3257-BF9F-4DAF-B34B-C1F20147605A Q33673025-37FDBCFC-C27A-4C5F-9D28-BE43AA619B8C Q33688557-76215773-C52E-4DB8-B33B-16921A28B11B Q33723516-6EB94F90-176F-4D2B-A373-97CD64E61FA3 Q33769602-01C55A9A-42F7-4B04-B2AE-8E9FA61EF88C Q33789101-8627BC50-606E-4D6E-899E-023446D886D7 Q33824444-A1987D91-8E9A-4525-8689-A8687E03C023 Q33834735-108EBC62-3473-4751-81EB-4B4FED4E1C52 Q33890630-206E8BC9-98AF-4B38-B2AD-31368F007994

P2860

Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease.

http://www.wikidata.org/entity/Q33911613

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Genome-wide expression profili ...... kers for Huntington's disease.

@ast

Genome-wide expression profili ...... kers for Huntington's disease.

@en

type

label

Genome-wide expression profili ...... kers for Huntington's disease.

@ast

Genome-wide expression profili ...... kers for Huntington's disease.

@en

prefLabel

Genome-wide expression profili ...... kers for Huntington's disease.

@ast

Genome-wide expression profili ...... kers for Huntington's disease.

@en

P1433

Q33911613-88C2E683-E4BA-4EFD-B984-616EB3A43329

P1476

Q33911613-A723250F-5619-43A9-A149-F3DFC5F1E826

P2093

Q33911613-44DFC0F7-C329-4B5C-AE52-2DDE283B599B

Q33911613-61B7B768-E0E4-47E2-A190-9E56BED20540

Q33911613-65CD2C81-77FB-4EF6-BE20-BF7F0863210D

Q33911613-6CA698C9-3F54-4DE8-B284-75FD9E81677C

Q33911613-7529A915-CFBF-4CC2-978E-32F24BBECFE4

Q33911613-A3BF8322-1A01-4554-AE8A-B14E7F6112E0

Q33911613-D400FD18-C3BD-476E-A766-B368B7DBF63E

Q33911613-D5544349-FDAF-4FA8-9257-8610BD217182

Q33911613-E29A102A-AE9C-4CB0-996C-771185789C0A

Q33911613-FB5FEB0A-193A-48C3-8F2B-4FFACE01B1EC

P2860

Q33911613-15418C39-94BC-43BF-8650-6A10F202B871

Q33911613-18978017-4D3F-4AAE-8BB9-7F3D85AFE618

Q33911613-189ABC11-0B83-42A4-A3B4-DFB6191A3F42

Q33911613-1A3405CE-3783-434A-9D1E-751BE774560E

Q33911613-399087FF-C2DB-4F77-A4B5-FA920B576C39

Q33911613-3D85B7EE-38D0-4993-933B-4CD1C9C7A347

Q33911613-49323B2B-0190-41EC-A1F4-5876D0D0397D

Q33911613-4B13860B-B9AE-4FF9-BDE0-6ECDC03FB46B

Q33911613-4D94323B-A500-426F-9A32-0174755F8A1E

Q33911613-541DB6DE-5F4E-4982-862E-C77352711B36

P304

Q33911613-13B6E418-A226-4448-9DDB-ACAA20C7AF17

P31

Q33911613-19825381-B527-4454-A568-F53E3FF2C2ED

P356

Q33911613-30635071-4783-49A1-B1D5-E94A7D0755EF

P407

Q33911613-B3D2ED1B-19F8-4C91-9AAE-D93749EF9781

P433

Q33911613-CC2DCB52-F9B1-4454-8639-65F74D725E9C

P478

Q33911613-4D008E16-4CF7-46F6-9D6B-6F6C7FCE7C34

P50

Q33911613-DDD433C2-E37F-4536-BA17-09648CFF0E92

P577

Q33911613-90180F9B-0CF2-481C-90CA-CC25E7D3A575

P5875

Q33911613-57595269-103C-4383-A8EB-48C9B312433B

P698

Q33911613-62B0E26D-7115-4939-BBB1-60CC04F9603D

P921

Q33911613-588333B0-D7FB-4499-A65C-CC8E705757E8

Q33911613-820E7AD3-6AC3-437F-B272-40C63013B130

P932

Q33911613-91F490AD-EA36-4443-A118-4C9CBF2CF2FB

P356

PNAS.0504921102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Genome-wide expression profili ...... rkers for Huntington's disease

@en

P2093

B Bouzou

http://www.w3.org/2001/XMLSchema#string

D Krainc

http://www.w3.org/2001/XMLSchema#string

F Borovecki

http://www.w3.org/2001/XMLSchema#string

F Then

http://www.w3.org/2001/XMLSchema#string

H D Rosas

http://www.w3.org/2001/XMLSchema#string

H Jeong

http://www.w3.org/2001/XMLSchema#string

J Zhou

http://www.w3.org/2001/XMLSchema#string

P Hogarth

http://www.w3.org/2001/XMLSchema#string

R V Jensen

http://www.w3.org/2001/XMLSchema#string

S M Hersch

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The hunt for huntingtin function: interaction partners tell many different stories

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.

Altered transcription in yeast expressing expanded polyglutamine.

Histone deacetylase inhibitors reduce polyglutamine toxicity

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

Transcriptional abnormalities in Huntington disease.

DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.

P304

11023-11028

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0504921102

http://www.w3.org/2001/XMLSchema#string

P407

P433

31

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7701359

http://www.w3.org/2001/XMLSchema#string

P698

16043692

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease

P932

1182457

http://www.w3.org/2001/XMLSchema#string